📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial. (2019)

First Author: Anderson CS

Attributed to: Imaging perfusion deficits and thrombolysis safety and efficacy in acute ischaemic stroke. The Third International funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(19)30038-8

PubMed Identifier: 30739745

Publication URI: http://europepmc.org/abstract/MED/30739745

Type: Journal Article/Review

Volume: 393

Parent Publication: Lancet (London, England)

Issue: 10174

ISSN: 0140-6736